Lupin has informed that it enclosed a Press Release as regards, use of Honeywell’s Solstice Air (HFO-1234ze cGMP) propellant by the Company, to transform respiratory care through the development of next-generation inhalers.
The above information is a part of company’s filings submitted to BSE.